Have you been diagnosed with Diabetic Retinopathy? (FAME)
We are testing the effect of a cholesterol lowering drug for its effectiveness in treating retinopathy in patients with Type 1 Diabetes. This drug, known as a fenofibrate, is already approved for treatment in Type 2 Diabetes, and it is hoped this study may expand treatment to cover Type 1 Diabetes as well.
In order to complete this study (referred to as FAME), we need volunteers from the public who meet a particular criteria. You may be eligible for this study if you are:
- aged 18 years or older
- have Type 1 Diabetes
- have been diagnosed with retinopathy in at least one eye
- have NOT had laser surgery or any other eye problems
You will be medically supervised and there will be no costs involved. For more information, with no obligation, please call:
Annette – Clinical Research Coordinator (02) 4963 2323 (take option 1).
Please do leave a message with your name and contact details so we can return your call.
This study has Human Research Ethics Committee (HREC) approval.
Register Your Interest
Please contact us now to learn more about participating in this Clinical Trial.